Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Brain-computer Interface System Market Research Report 2026
Global Brain-computer Interface System Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-07-26
Pages: 161 Pages
Report ld: 6572203
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY FINDINGS
2025 global deliveries reached approximately 440,000 Brain-computer Interface Systems
Average manufacturer selling price was approximately US$1,900 per delivered system
Non-invasive systems represented the majority of global unit shipments
Medical and research applications concentrated most professional system value
Brain-computer Interface System Market Size(US$)
CAGR 2026-2032
20.4%
Market Size,2032
USD 2,962
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 972 million
Market Forecast in 2032(Value)
US$ 2,962 million
CAGR
20.4%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Brain-computer Interface System market was valued at US$ 836 million in 2025 and is anticipated to reach US$ 2962 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Brain-computer Interface System refers to an integrated hardware-software system that establishes a direct information pathway between neural activity and computers, assistive devices, rehabilitation equipment, robots, transportation systems or neuromodulation devices. Also referred to as a BCI system or brain-machine interface system, the product normally combines neural-signal electrodes or implantable interfaces, low-noise analog front ends, amplification and digital conversion modules, wired or wireless transmission, real-time preprocessing and neural-decoding software, application management software, and an external control, feedback or stimulation device. The research scope covers non-invasive systems based mainly on EEG, fNIRS or MEG; semi-invasive systems using epidural, cortical-surface or endovascular interfaces; and invasive systems using intracortical penetrating electrodes to capture spikes and local field potentials. Products range from low-channel portable headsets to high-density platforms exceeding 128 channels. Their core functions include neural-state recognition, movement-intention decoding, communication restoration, external-device control, neurofeedback, functional compensation, rehabilitation training and closed-loop neurological treatment. The market focuses on deliverable system-level products with proprietary acquisition hardware, integrated decoding functions and an identifiable interaction or feedback workflow across medical, research, consumer, industrial, transportation and specialized applications.
MARKET TRENDS
The Brain-computer Interface System market is shifting from competition in standalone EEG amplifiers or wearable headsets toward competition in complete neural-interaction architectures. Customers increasingly assess signal-to-noise ratio, synchronization accuracy, motion-artifact suppression, preparation time, decoding latency, cross-session stability, software openness and compatibility with external equipment rather than relying on channel count alone. Non-invasive products are moving toward dry or semi-dry electrodes, wireless acquisition, compact form factors, real-time APIs and multimodal synchronization with eye tracking, EMG, motion capture, stimulation, virtual reality and robotics. Semi-invasive systems are developing along epidural, cortical-surface and endovascular routes that seek a balance between information quality, surgical complexity and long-term stability. Intracortical platforms continue to pursue higher-density neuronal recording for precise cursor, speech and robotic control, but face more demanding implantation, packaging and calibration requirements. The long-term product direction is an adaptive closed loop in which signal acquisition, decoding, device control and sensory or therapeutic feedback are continuously optimized as one system. Commercial differentiation is consequently migrating toward proprietary neural datasets, application-specific workflows, automated calibration, home-use capability and longitudinal performance rather than basic access to raw brain signals.
MARKET SEGMENTATION
By Company
- Neuralink
- OpenBCI
- NeuroPace
- Emotiv
- NeuroSky
- ANT Neuro
- Blackrock Neurotech
- Synchron
- g.tec medical engineering GmbH
- Brain Products
- Bitbrain
- Precision Neuroscience
- Paradromics
- InteraXon
- Neurable
- Mentalab
- mBrainTrain
- Neuroelectrics
- CGX Systems (formerly Cognionics)
- Neurosity
- Wearable Sensing
- Compumedics Neuroscan
- SmartCap(Wenco)
- Shimadzu
- BrainCo
- Neuracle Technology
- CUSOFT
- Deayea
- Entertech
- HNNK
- StairMed
- NeuroXess
- Enlight Medical
- Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
- Hanix
- Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
- Beijing Xinzhida Neural Technology Co., Ltd
- Nanjing Vishee Medical Technology Co., Ltd.
- Xiangyu Medical Co.,Ltd.
- Jiangsu Apon Medical Technology Co.,Ltd.
- Boling Brain Machine (Hangzhou) Technology Co., Ltd.
- Medlander
- Shanghai HeartCare Medical Technology Corporation Limited
- Beijing Chieftain Control Engineering Technology Co., Ltd.
- Kingfar International,Inc.
- Suzhou Nianji Intelligent Technology Co., Ltd.
- Beijing Zhiran Medical Technology Co., Ltd
- Greatthink Medical Technology
- Danyang Huichuang Medical Equipment Co., Ltd.
- OYMotion
- Aura MedTech
- Casibrain
- Gestala
- WE-LINKING
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Non-Invasive
- Partially Invasive
- Invasive
Segment by Application
- Medical Rehabilitation
- Daily Life and Entertainment Consumption
- Industrial Control
- Traffic Driving
- Research & Education
- Military and Others
Segment by Category
- 1 To 8 Channels
- 9 To 32 Channels
- 33 To 128 Channels
- 128 To 256 Channels
Segment by Division
- EEG
- ECoG
- Spikes & LFPs
- fNIRS, MEG and Others
MARKET DYNAMICS
Drivers
Growth is being driven by converging demand from neuroscience research, neurological rehabilitation, functional compensation, assistive communication and closed-loop treatment. Universities and research institutions require configurable systems for neuro-AI, cognitive neuroscience, multimodal experiments and human-machine interaction, while hospitals need products capable of producing measurable clinical or functional outcomes for patients with spinal-cord injury, stroke, epilepsy and severe communication impairment. Improvements in flexible electrodes, low-noise analog front ends, wireless transmission, embedded computing and machine-learning decoding are making systems more portable and usable outside controlled laboratories. Policy and payment infrastructure are also beginning to move in parallel with technology. China’s brain-computer interface industrial policy identifies electrodes, dedicated chips, complete systems, standards and medical, industrial and consumer applications as priority development areas. The National Healthcare Security Administration has established service-price categories for invasive implantation, device removal and non-invasive fitting, while the NMPA approved an implantable hand-function compensation system in March 2026. These developments reduce uncertainty around clinical workflow and create a more defined transition from research projects to regulated product deployment.
Restraints
The principal restraint is the performance gap between laboratory demonstration and reliable daily use. Non-invasive EEG systems are affected by skull attenuation, electrode-contact variation, muscle and eye artefacts, head movement and environmental noise, making decoding accuracy and repeatability highly dependent on the user, task and operating environment. Additional channels may improve spatial coverage but also increase preparation time, calibration complexity, data-processing requirements and operator dependence. Semi-invasive and invasive systems carry substantially higher development and delivery costs related to biocompatible materials, microfabrication, hermetic packaging, sterile production, neurosurgery, clinical trials and long-term follow-up. Endovascular approaches must manage vascular access, anatomical limitations and antithrombotic requirements, while cortical-surface and intracortical systems face infection, tissue response, electrode migration and signal degradation risks. Medical adoption also depends on physician training, hospital capacity, reimbursement and evidence that benefits persist beyond selected clinical-study participants. These limitations create a highly uneven market in which low-cost systems can scale rapidly by volume, while high-value medical systems require long commercialization cycles and significant post-market support.
Opportunities
The most immediate opportunities lie in converting general-purpose neural acquisition platforms into validated systems for defined workflows. Home and community rehabilitation can combine portable EEG hardware, intention decoding, robotic gloves, functional electrical stimulation or exoskeletons with clinician-facing software and remote model updates. Assistive communication products can extend from cursor control to text generation, environmental control and robotic-device operation for patients with paralysis or amyotrophic lateral sclerosis. Closed-loop neurological treatment offers a separate high-value opportunity in which continuous neural monitoring triggers personalized stimulation, with epilepsy providing the most established commercial model. Consumer and enterprise products may integrate brain sensing into headphones, headbands, VR equipment, safety wearables and driver-monitoring systems, provided that measurable benefits justify continued use. Semi-invasive systems may open a clinically relevant middle path between non-invasive accessibility and intracortical information density. China’s approval of an epidural hand-function compensation system, Precision Neuroscience’s FDA-cleared cortical interface, and advancing endovascular and intracortical clinical programs indicate that multiple interface routes can coexist rather than converge on a single dominant architecture.
Challenges
Long-term market development requires technical reliability, clinical evidence, regulatory compliance and sustainable economics to be achieved simultaneously. Neural signals differ materially across users and drift over time, creating persistent challenges in model transfer, recalibration and performance validation. Implantable systems must maintain signal quality while minimizing heat, power consumption, tissue reaction, wireless-transmission failure and replacement risk. The sector also lacks fully harmonized terminology, performance benchmarks, channel-count definitions, data formats and interoperability standards, complicating product comparison and multi-centre validation. Brain data introduces additional requirements around informed consent, cybersecurity, data ownership, mental privacy and the permitted use of neural information. Commercial risk is equally important. Consumer products may show measurable neural-state signals without delivering sufficient recurring utility, while medical companies can generate high product gross margins but still incur substantial clinical, regulatory, physician-training and sales expenses. Scaling therefore depends not only on decoding accuracy but also on standard surgical procedures, application-specific evidence, reimbursement, service capacity and the ability to support patients over extended periods.
INDUSTRY CHAIN ANALYSIS
The upstream Brain-computer Interface System chain consists of wet, dry and semi-dry scalp electrodes; flexible epidural and cortical electrode arrays; penetrating microelectrodes; endovascular electrode structures; conductive and biocompatible materials; hermetic packaging; low-noise amplifiers; analog front-end chips; ADCs; processors; wireless-communication and power modules; batteries; connectors; surgical tools; stimulation modules; and precision mechanical components. Upstream specifications determine signal amplitude, bandwidth, spatial resolution, channel density, noise, power consumption, thermal safety, comfort, implantation difficulty and long-term stability. Non-invasive products place greater emphasis on electrode consistency, ergonomic wearability, rapid setup and resistance to motion artefacts. Implantable products allocate more value and development expenditure to microfabrication, flexible materials, packaging reliability, sterilization, wireless power and surgical compatibility.
Midstream manufacturers integrate the neural interface, acquisition electronics, signal transmission, real-time decoding, application software and external feedback device into a deliverable system. Value creation is concentrated in reproducible signal acquisition, low-latency processing, automated calibration, cross-session model stability, integration with third-party devices and regulatory or clinical validation. Standardized low-channel hardware faces increasing price competition, shifting profit toward software licenses, development tools, validated application modules, consumables and technical services. Research-grade and medical systems retain stronger pricing power because customers require data quality, synchronization, technical support and workflow continuity. Implantable and closed-loop systems can achieve high product margins, but those margins must fund clinical trials, quality systems, regulatory submissions, surgical training and long-term patient management. Downstream customers include universities, hospitals, rehabilitation centres, neurological clinics, assistive-technology providers, consumer-electronics companies, industrial operators, transportation users and specialized government institutions.
SEGMENT INSIGHTS
By interface type, non-invasive systems account for the majority of shipments because they offer lower risk, broader availability and shorter procurement cycles across education, research, consumer interaction and rehabilitation. Semi-invasive systems cover epidural, cortical-surface and endovascular routes that record population-level cortical activity without penetrating neural tissue. These architectures generally offer stronger and more spatially specific signals than scalp EEG while reducing some of the tissue-response risks associated with intracortical arrays. Intracortical systems record spikes and local field potentials and provide the highest potential information density for precise movement, speech and sensory decoding, but their deployment remains constrained by surgical risk, long-term signal stability and high development costs. EEG remains the dominant signal modality by unit volume, while ECoG, spikes and LFPs concentrate high-value clinical and advanced research activity. fNIRS, MEG and multimodal configurations occupy specialized research, cognitive assessment and hybrid-interface niches.
Low-channel 1–8 and 9–32-channel products dominate portable, educational, consumer and rapid-development applications. Systems in the 33–128-channel range serve advanced neuroscience, high-density EEG, brain mapping and complex multimodal experiments, while platforms above 128 channels, including 128–256-channel and higher-density configurations, support detailed cortical recording and advanced implantable research. Price and margin differences between these segments are substantial. Neuracle Technology’s prospectus reported 488 EEG acquisition systems sold in 2025 at an average tax-exclusive price of RMB159,100 per system and a 77.92% gross margin, demonstrating the economics of specialized professional equipment relative to the global weighted average price. Within applications, research and education provide the broadest established customer base, while medical rehabilitation, functional compensation and neurological treatment concentrate higher system value. Daily-life consumption, industrial control and transportation remain earlier-stage markets in which adoption depends on comfort, calibration speed and demonstrable operational benefits.
DOWNSTREAM MARKET OPPORTUNITIES
Downstream demand is becoming more application-specific. Research users require raw-data access, precise event synchronization, configurable channels and compatibility with MATLAB, Python, BCI2000, OpenViBE and multimodal laboratory equipment. Medical customers require repeatable protocols, clinical-grade reliability, therapist or physician interfaces and connectivity with robotic gloves, functional electrical stimulation, wheelchairs, prostheses and neuromodulation equipment. In rehabilitation, the commercial opportunity increasingly combines immediate functional compensation with repeated training intended to promote longer-term recovery. Closed-loop treatment customers place greater emphasis on biomarker detection, stimulation accuracy, longitudinal data and patient-management services. Daily-life and entertainment products require unobtrusive form factors and minimal calibration; industrial and transportation applications require robust state monitoring under motion, vibration and electromagnetic interference. Military and specialized government applications are more likely to focus on training, cognitive-load assessment, fatigue monitoring and complex human-machine interaction. Across these markets, suppliers able to deliver a validated end-to-end workflow rather than a generic signal stream are positioned to capture a larger proportion of downstream value.
REGIONAL INSIGHTS
Fastest-Growing Region: Asia Pacific
North America remains the principal high-value clinical and venture-backed development region. It contains commercially established closed-loop neurological treatment, intracortical clinical programs, endovascular systems and cortical-surface interfaces. NeuroPace provides a commercial benchmark: its RNS System generated US$81.7 million in 2025 revenue with an 81.9% product gross margin. Neuralink is conducting trials for computer and robotic-arm control, Synchron is evaluating an investigational endovascular system, Precision Neuroscience has obtained FDA clearance for its cortical interface, and Paradromics received authorization to initiate a clinical study of its fully implantable system. The region’s advantages include specialist clinical centres, regulatory experience, medical-device financing and access to software and AI capabilities, although development and patient-support costs remain high.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
BY TYPE,2021-2032(US $ MILLION)
Non-Invasive
Partially Invasive
Invasive
BY APPLICATION，2021-2032(US $ MILLION）
Medical Rehabilitation
Daily Life and Entertainment Consumption
Industrial Control
Traffic Driving
Research & Education
Military and Others
Europe has a strong position in research-grade EEG, neurorehabilitation, multimodal acquisition and open scientific software ecosystems, supported by companies such as g.tec, Brain Products, ANT Neuro, Bitbrain, Mentalab, mBrainTrain and Neuroelectrics. China is developing a broader manufacturing and application base spanning non-invasive research systems, rehabilitation equipment, consumer products and multiple implantable routes. The NMPA approval of an epidural Brain-computer Interface System, the establishment of medical-service price categories and expanding clinical programs have strengthened China’s position in early medical commercialization. Japan retains capabilities in fNIRS, MEG and clinical neurodiagnostic equipment, while South Korea, Taiwan and Southeast Asia remain more concentrated in research institutions, components, clinical collaboration and application development than in globally scaled system brands. Regional competition is therefore differentiated: North America leads high-value clinical innovation, Europe remains strong in research platforms, and China is accelerating full-chain localization and clinical deployment.
COMPETITIVE LANDSCAPE ANALYSIS
The Brain-computer Interface System market has a layered competitive structure. In commercial non-invasive research and development platforms, g.tec, Brain Products, ANT Neuro, OpenBCI, Emotiv, NeuroSky, Bitbrain, Neuroelectrics, Mentalab, mBrainTrain, CGX Systems, Wearable Sensing, Compumedics Neuroscan, Neuracle Technology and BrainCo compete through signal quality, channel density, wireless performance, electrode preparation, synchronization, software openness and global research-channel coverage. InteraXon, Neurable, Neurosity and SmartCap emphasize consumer, enterprise or industrial form factors and applied neural-state interaction. In medical rehabilitation, Chinese suppliers such as BrainCo, Neuracle Technology, CUSOFT, Deayea, Entertech, HNNK, Vishee Medical, Xiangyu Medical, Medlander, Longest and other specialist developers compete through hospital access, rehabilitation-device integration and localized clinical service. The implantable and closed-loop segment is technologically fragmented: Neuralink, Paradromics and Blackrock Neurotech pursue intracortical interfaces; Precision Neuroscience focuses on cortical-surface access; Synchron uses an endovascular route; NeuroPace operates an established responsive neurostimulation business; and Neuracle Technology has commercialized an epidural functional-compensation system in China. StairMed, NeuroXess, Enlight Medical, Xinzhida, Zhirun Medical and other Chinese developers are advancing different implantable architectures and clinical pipelines. Competitive advantage increasingly depends on control of the complete stack—electrodes, acquisition chips, wireless transmission, decoding software, clinical data, regulatory evidence, external devices and long-term service. Scale in low-cost hardware alone is unlikely to establish durable leadership, while companies possessing validated workflows and proprietary longitudinal neural data can sustain stronger pricing and higher entry barriers.
REPORT SCOPE
This report delivers a comprehensive overview of the global Brain-computer Interface System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Brain-computer Interface System. The Brain-computer Interface System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Brain-computer Interface System market comprehensively. Regional market sizes by Type, by Application, by Signal Acquisition Channel Count, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Brain-computer Interface System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Signal Acquisition Channel Count, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Brain-computer Interface System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Brain-computer Interface System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Brain-computer Interface System Market Overview
1.1 Product Definition
1.2 Brain-computer Interface System by Type
1.2.1 Global Brain-computer Interface System Market Value by Type: 2025 vs 2032
1.2.2 Non-Invasive
1.2.3 Partially Invasive
1.2.4 Invasive
1.3 Brain-computer Interface System by Signal Acquisition Channel Count
1.3.1 Global Brain-computer Interface System Market Value by Signal Acquisition Channel Count: 2025 vs 2032
1.3.2 1 To 8 Channels
1.3.3 9 To 32 Channels
1.3.4 33 To 128 Channels
1.3.5 128 To 256 Channels
1.4 Brain-computer Interface System by Primary Signal Modality
1.4.1 Global Brain-computer Interface System Market Value by Primary Signal Modality: 2025 vs 2032
1.4.2 EEG
1.4.3 ECoG
1.4.4 Spikes & LFPs
1.4.5 fNIRS, MEG and Others
1.5 Brain-computer Interface System by Application
1.5.1 Global Brain-computer Interface System Market Value by Application: 2025 vs 2032
1.5.2 Medical Rehabilitation
1.5.3 Daily Life and Entertainment Consumption
1.5.4 Industrial Control
1.5.5 Traffic Driving
1.5.6 Research & Education
1.5.7 Military and Others
1.6 Global Brain-computer Interface System Market Size Estimates and Forecasts
1.6.1 Global Brain-computer Interface System Revenue 2021–2032
1.6.2 Global Brain-computer Interface System Sales 2021–2032
1.6.3 Global Brain-computer Interface System Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Brain-computer Interface System Market Competition by Manufacturers
2.1 Global Brain-computer Interface System Sales Market Share by Manufacturers (2021–2026)
2.2 Global Brain-computer Interface System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Brain-computer Interface System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Brain-computer Interface System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Brain-computer Interface System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Brain-computer Interface System, Product Types and Applications
2.7 Global Key Manufacturers of Brain-computer Interface System, Date of Entry into the Industry
2.8 Global Brain-computer Interface System Market Competitive Situation and Trends
2.8.1 Global Brain-computer Interface System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Brain-computer Interface System Players Market Share by Revenue
2.8.3 Global Brain-computer Interface System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Brain-computer Interface System Market Scenario by Region
3.1 Global Brain-computer Interface System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Brain-computer Interface System Sales by Region: 2021–2032
3.2.1 Global Brain-computer Interface System Sales by Region: 2021–2026
3.2.2 Global Brain-computer Interface System Sales by Region: 2027–2032
3.3 Global Brain-computer Interface System Revenue by Region: 2021–2032
3.3.1 Global Brain-computer Interface System Revenue by Region: 2021–2026
3.3.2 Global Brain-computer Interface System Revenue by Region: 2027–2032
3.4 North America Brain-computer Interface System Market Facts & Figures by Country
3.4.1 North America Brain-computer Interface System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Brain-computer Interface System Sales by Country (2021–2032)
3.4.3 North America Brain-computer Interface System Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Brain-computer Interface System Market Facts & Figures by Country
3.5.1 Europe Brain-computer Interface System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Brain-computer Interface System Sales by Country (2021–2032)
3.5.3 Europe Brain-computer Interface System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brain-computer Interface System Market Facts & Figures by Region
3.6.1 Asia Pacific Brain-computer Interface System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Brain-computer Interface System Sales by Region (2021–2032)
3.6.3 Asia Pacific Brain-computer Interface System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Brain-computer Interface System Market Facts & Figures by Country
3.7.1 Latin America Brain-computer Interface System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Brain-computer Interface System Sales by Country (2021–2032)
3.7.3 Latin America Brain-computer Interface System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Brain-computer Interface System Market Facts & Figures by Country
3.8.1 Middle East and Africa Brain-computer Interface System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Brain-computer Interface System Sales by Country (2021–2032)
3.8.3 Middle East and Africa Brain-computer Interface System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Brain-computer Interface System Sales by Type (2021–2032)
4.1.1 Global Brain-computer Interface System Sales by Type (2021–2026)
4.1.2 Global Brain-computer Interface System Sales by Type (2027–2032)
4.1.3 Global Brain-computer Interface System Sales Market Share by Type (2021–2032)
4.2 Global Brain-computer Interface System Revenue by Type (2021–2032)
4.2.1 Global Brain-computer Interface System Revenue by Type (2021–2026)
4.2.2 Global Brain-computer Interface System Revenue by Type (2027–2032)
4.2.3 Global Brain-computer Interface System Revenue Market Share by Type (2021–2032)
4.3 Global Brain-computer Interface System Price by Type (2021–2032)
5 Segment by Application
5.1 Global Brain-computer Interface System Sales by Application (2021–2032)
5.1.1 Global Brain-computer Interface System Sales by Application (2021–2026)
5.1.2 Global Brain-computer Interface System Sales by Application (2027–2032)
5.1.3 Global Brain-computer Interface System Sales Market Share by Application (2021–2032)
5.2 Global Brain-computer Interface System Revenue by Application (2021–2032)
5.2.1 Global Brain-computer Interface System Revenue by Application (2021–2026)
5.2.2 Global Brain-computer Interface System Revenue by Application (2027–2032)
5.2.3 Global Brain-computer Interface System Revenue Market Share by Application (2021–2032)
5.3 Global Brain-computer Interface System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Neuralink
6.1.1 Neuralink Company Information
6.1.2 Neuralink Description and Business Overview
6.1.3 Neuralink Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Neuralink Brain-computer Interface System Product Portfolio
6.1.5 Neuralink Recent Developments/Updates
6.2 OpenBCI
6.2.1 OpenBCI Company Information
6.2.2 OpenBCI Description and Business Overview
6.2.3 OpenBCI Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 OpenBCI Brain-computer Interface System Product Portfolio
6.2.5 OpenBCI Recent Developments/Updates
6.3 NeuroPace
6.3.1 NeuroPace Company Information
6.3.2 NeuroPace Description and Business Overview
6.3.3 NeuroPace Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 NeuroPace Brain-computer Interface System Product Portfolio
6.3.5 NeuroPace Recent Developments/Updates
6.4 Emotiv
6.4.1 Emotiv Company Information
6.4.2 Emotiv Description and Business Overview
6.4.3 Emotiv Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Emotiv Brain-computer Interface System Product Portfolio
6.4.5 Emotiv Recent Developments/Updates
6.5 NeuroSky
6.5.1 NeuroSky Company Information
6.5.2 NeuroSky Description and Business Overview
6.5.3 NeuroSky Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 NeuroSky Brain-computer Interface System Product Portfolio
6.5.5 NeuroSky Recent Developments/Updates
6.6 ANT Neuro
6.6.1 ANT Neuro Company Information
6.6.2 ANT Neuro Description and Business Overview
6.6.3 ANT Neuro Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ANT Neuro Brain-computer Interface System Product Portfolio
6.6.5 ANT Neuro Recent Developments/Updates
6.7 Blackrock Neurotech
6.7.1 Blackrock Neurotech Company Information
6.7.2 Blackrock Neurotech Description and Business Overview
6.7.3 Blackrock Neurotech Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Blackrock Neurotech Brain-computer Interface System Product Portfolio
6.7.5 Blackrock Neurotech Recent Developments/Updates
6.8 Synchron
6.8.1 Synchron Company Information
6.8.2 Synchron Description and Business Overview
6.8.3 Synchron Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Synchron Brain-computer Interface System Product Portfolio
6.8.5 Synchron Recent Developments/Updates
6.9 g.tec medical engineering GmbH
6.9.1 g.tec medical engineering GmbH Company Information
6.9.2 g.tec medical engineering GmbH Description and Business Overview
6.9.3 g.tec medical engineering GmbH Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 g.tec medical engineering GmbH Brain-computer Interface System Product Portfolio
6.9.5 g.tec medical engineering GmbH Recent Developments/Updates
6.10 Brain Products
6.10.1 Brain Products Company Information
6.10.2 Brain Products Description and Business Overview
6.10.3 Brain Products Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Brain Products Brain-computer Interface System Product Portfolio
6.10.5 Brain Products Recent Developments/Updates
6.11 Bitbrain
6.11.1 Bitbrain Company Information
6.11.2 Bitbrain Description and Business Overview
6.11.3 Bitbrain Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Bitbrain Brain-computer Interface System Product Portfolio
6.11.5 Bitbrain Recent Developments/Updates
6.12 Precision Neuroscience
6.12.1 Precision Neuroscience Company Information
6.12.2 Precision Neuroscience Description and Business Overview
6.12.3 Precision Neuroscience Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Precision Neuroscience Brain-computer Interface System Product Portfolio
6.12.5 Precision Neuroscience Recent Developments/Updates
6.13 Paradromics
6.13.1 Paradromics Company Information
6.13.2 Paradromics Description and Business Overview
6.13.3 Paradromics Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Paradromics Brain-computer Interface System Product Portfolio
6.13.5 Paradromics Recent Developments/Updates
6.14 InteraXon
6.14.1 InteraXon Company Information
6.14.2 InteraXon Description and Business Overview
6.14.3 InteraXon Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 InteraXon Brain-computer Interface System Product Portfolio
6.14.5 InteraXon Recent Developments/Updates
6.15 Neurable
6.15.1 Neurable Company Information
6.15.2 Neurable Description and Business Overview
6.15.3 Neurable Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Neurable Brain-computer Interface System Product Portfolio
6.15.5 Neurable Recent Developments/Updates
6.16 Mentalab
6.16.1 Mentalab Company Information
6.16.2 Mentalab Description and Business Overview
6.16.3 Mentalab Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Mentalab Brain-computer Interface System Product Portfolio
6.16.5 Mentalab Recent Developments/Updates
6.17 mBrainTrain
6.17.1 mBrainTrain Company Information
6.17.2 mBrainTrain Description and Business Overview
6.17.3 mBrainTrain Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 mBrainTrain Brain-computer Interface System Product Portfolio
6.17.5 mBrainTrain Recent Developments/Updates
6.18 Neuroelectrics
6.18.1 Neuroelectrics Company Information
6.18.2 Neuroelectrics Description and Business Overview
6.18.3 Neuroelectrics Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Neuroelectrics Brain-computer Interface System Product Portfolio
6.18.5 Neuroelectrics Recent Developments/Updates
6.19 CGX Systems (formerly Cognionics)
6.19.1 CGX Systems (formerly Cognionics) Company Information
6.19.2 CGX Systems (formerly Cognionics) Description and Business Overview
6.19.3 CGX Systems (formerly Cognionics) Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 CGX Systems (formerly Cognionics) Brain-computer Interface System Product Portfolio
6.19.5 CGX Systems (formerly Cognionics) Recent Developments/Updates
6.20 Neurosity
6.20.1 Neurosity Company Information
6.20.2 Neurosity Description and Business Overview
6.20.3 Neurosity Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Neurosity Brain-computer Interface System Product Portfolio
6.20.5 Neurosity Recent Developments/Updates
6.21 Wearable Sensing
6.21.1 Wearable Sensing Company Information
6.21.2 Wearable Sensing Description and Business Overview
6.21.3 Wearable Sensing Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Wearable Sensing Brain-computer Interface System Product Portfolio
6.21.5 Wearable Sensing Recent Developments/Updates
6.22 Compumedics Neuroscan
6.22.1 Compumedics Neuroscan Company Information
6.22.2 Compumedics Neuroscan Description and Business Overview
6.22.3 Compumedics Neuroscan Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Compumedics Neuroscan Brain-computer Interface System Product Portfolio
6.22.5 Compumedics Neuroscan Recent Developments/Updates
6.23 SmartCap(Wenco)
6.23.1 SmartCap(Wenco) Company Information
6.23.2 SmartCap(Wenco) Description and Business Overview
6.23.3 SmartCap(Wenco) Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 SmartCap(Wenco) Brain-computer Interface System Product Portfolio
6.23.5 SmartCap(Wenco) Recent Developments/Updates
6.24 Shimadzu
6.24.1 Shimadzu Company Information
6.24.2 Shimadzu Description and Business Overview
6.24.3 Shimadzu Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Shimadzu Brain-computer Interface System Product Portfolio
6.24.5 Shimadzu Recent Developments/Updates
6.25 BrainCo
6.25.1 BrainCo Company Information
6.25.2 BrainCo Description and Business Overview
6.25.3 BrainCo Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 BrainCo Brain-computer Interface System Product Portfolio
6.25.5 BrainCo Recent Developments/Updates
6.26 Neuracle Technology
6.26.1 Neuracle Technology Company Information
6.26.2 Neuracle Technology Description and Business Overview
6.26.3 Neuracle Technology Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Neuracle Technology Brain-computer Interface System Product Portfolio
6.26.5 Neuracle Technology Recent Developments/Updates
6.27 CUSOFT
6.27.1 CUSOFT Company Information
6.27.2 CUSOFT Description and Business Overview
6.27.3 CUSOFT Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 CUSOFT Brain-computer Interface System Product Portfolio
6.27.5 CUSOFT Recent Developments/Updates
6.28 Deayea
6.28.1 Deayea Company Information
6.28.2 Deayea Description and Business Overview
6.28.3 Deayea Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Deayea Brain-computer Interface System Product Portfolio
6.28.5 Deayea Recent Developments/Updates
6.29 Entertech
6.29.1 Entertech Company Information
6.29.2 Entertech Description and Business Overview
6.29.3 Entertech Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Entertech Brain-computer Interface System Product Portfolio
6.29.5 Entertech Recent Developments/Updates
6.30 HNNK
6.30.1 HNNK Company Information
6.30.2 HNNK Description and Business Overview
6.30.3 HNNK Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.30.4 HNNK Brain-computer Interface System Product Portfolio
6.30.5 HNNK Recent Developments/Updates
6.31 StairMed
6.31.1 StairMed Company Information
6.31.2 StairMed Description and Business Overview
6.31.3 StairMed Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.31.4 StairMed Brain-computer Interface System Product Portfolio
6.31.5 StairMed Recent Developments/Updates
6.32 NeuroXess
6.32.1 NeuroXess Company Information
6.32.2 NeuroXess Description and Business Overview
6.32.3 NeuroXess Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.32.4 NeuroXess Brain-computer Interface System Product Portfolio
6.32.5 NeuroXess Recent Developments/Updates
6.33 Enlight Medical
6.33.1 Enlight Medical Company Information
6.33.2 Enlight Medical Description and Business Overview
6.33.3 Enlight Medical Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.33.4 Enlight Medical Brain-computer Interface System Product Portfolio
6.33.5 Enlight Medical Recent Developments/Updates
6.34 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
6.34.1 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Company Information
6.34.2 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Description and Business Overview
6.34.3 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.34.4 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Product Portfolio
6.34.5 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Recent Developments/Updates
6.35 Hanix
6.35.1 Hanix Company Information
6.35.2 Hanix Description and Business Overview
6.35.3 Hanix Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.35.4 Hanix Brain-computer Interface System Product Portfolio
6.35.5 Hanix Recent Developments/Updates
6.36 Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
6.36.1 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Company Information
6.36.2 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Description and Business Overview
6.36.3 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.36.4 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Product Portfolio
6.36.5 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Recent Developments/Updates
6.37 Beijing Xinzhida Neural Technology Co., Ltd
6.37.1 Beijing Xinzhida Neural Technology Co., Ltd Company Information
6.37.2 Beijing Xinzhida Neural Technology Co., Ltd Description and Business Overview
6.37.3 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.37.4 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Product Portfolio
6.37.5 Beijing Xinzhida Neural Technology Co., Ltd Recent Developments/Updates
6.38 Nanjing Vishee Medical Technology Co., Ltd.
6.38.1 Nanjing Vishee Medical Technology Co., Ltd. Company Information
6.38.2 Nanjing Vishee Medical Technology Co., Ltd. Description and Business Overview
6.38.3 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.38.4 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Product Portfolio
6.38.5 Nanjing Vishee Medical Technology Co., Ltd. Recent Developments/Updates
6.39 Xiangyu Medical Co.,Ltd.
6.39.1 Xiangyu Medical Co.,Ltd. Company Information
6.39.2 Xiangyu Medical Co.,Ltd. Description and Business Overview
6.39.3 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.39.4 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Product Portfolio
6.39.5 Xiangyu Medical Co.,Ltd. Recent Developments/Updates
6.40 Jiangsu Apon Medical Technology Co.,Ltd.
6.40.1 Jiangsu Apon Medical Technology Co.,Ltd. Company Information
6.40.2 Jiangsu Apon Medical Technology Co.,Ltd. Description and Business Overview
6.40.3 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales, Revenue, and Gross Margin (2021–2026)
6.40.4 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Product Portfolio
6.40.5 Jiangsu Apon Medical Technology Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brain-computer Interface System Industry Chain Analysis
7.2 Brain-computer Interface System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brain-computer Interface System Production Mode & Process Analysis
7.4 Brain-computer Interface System Sales and Marketing
7.4.1 Brain-computer Interface System Sales Channels
7.4.2 Brain-computer Interface System Distributors
7.5 Brain-computer Interface System Customer Analysis
8 Brain-computer Interface System Market Dynamics
8.1 Brain-computer Interface System Industry Trends
8.2 Brain-computer Interface System Market Drivers
8.3 Brain-computer Interface System Market Challenges
8.4 Brain-computer Interface System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Brain-computer Interface System Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Brain-computer Interface System Market Value by Signal Acquisition Channel Count (US$ Million), 2025 vs 2032
Table 3. Global Brain-computer Interface System Market Value by Primary Signal Modality (US$ Million), 2025 vs 2032
Table 4. Global Brain-computer Interface System Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Brain-computer Interface System Market Competitive Situation by Manufacturers in 2025
Table 6. Global Brain-computer Interface System Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Brain-computer Interface System Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Brain-computer Interface System Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Brain-computer Interface System Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Brain-computer Interface System Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Brain-computer Interface System, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Brain-computer Interface System, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Brain-computer Interface System, Product Types and Applications
Table 14. Global Key Manufacturers of Brain-computer Interface System, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Brain-computer Interface System Companies by Tier (Tier 1, Tier 2, Tier 3), based on Brain-computer Interface System Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Brain-computer Interface System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Brain-computer Interface System Sales by Region (K Units), 2021–2026
Table 20. Global Brain-computer Interface System Sales Market Share by Region (2021–2026)
Table 21. Global Brain-computer Interface System Sales by Region (K Units), 2027–2032
Table 22. Global Brain-computer Interface System Sales Market Share by Region (2027–2032)
Table 23. Global Brain-computer Interface System Revenue by Region (US$ Million), 2021–2026
Table 24. Global Brain-computer Interface System Revenue Market Share by Region (2021–2026)
Table 25. Global Brain-computer Interface System Revenue by Region (US$ Million), 2027–2032
Table 26. Global Brain-computer Interface System Revenue Market Share by Region (2027–2032)
Table 27. North America Brain-computer Interface System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Brain-computer Interface System Sales by Country (K Units), 2021–2026
Table 29. North America Brain-computer Interface System Sales by Country (K Units), 2027–2032
Table 30. North America Brain-computer Interface System Revenue by Country (US$ Million), 2021–2026
Table 31. North America Brain-computer Interface System Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Brain-computer Interface System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Brain-computer Interface System Sales by Country (K Units), 2021–2026
Table 34. Europe Brain-computer Interface System Sales by Country (K Units), 2027–2032
Table 35. Europe Brain-computer Interface System Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Brain-computer Interface System Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Brain-computer Interface System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Brain-computer Interface System Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Brain-computer Interface System Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Brain-computer Interface System Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Brain-computer Interface System Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Brain-computer Interface System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Brain-computer Interface System Sales by Country (K Units), 2021–2026
Table 44. Latin America Brain-computer Interface System Sales by Country (K Units), 2027–2032
Table 45. Latin America Brain-computer Interface System Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Brain-computer Interface System Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Brain-computer Interface System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Brain-computer Interface System Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Brain-computer Interface System Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Brain-computer Interface System Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Brain-computer Interface System Revenue by Country (US$ Million), 2027–2032
Table 52. Global Brain-computer Interface System Sales (K Units) by Type (2021–2026)
Table 53. Global Brain-computer Interface System Sales (K Units) by Type (2027–2032)
Table 54. Global Brain-computer Interface System Sales Market Share by Type (2021–2026)
Table 55. Global Brain-computer Interface System Sales Market Share by Type (2027–2032)
Table 56. Global Brain-computer Interface System Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Brain-computer Interface System Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Brain-computer Interface System Revenue Market Share by Type (2021–2026)
Table 59. Global Brain-computer Interface System Revenue Market Share by Type (2027–2032)
Table 60. Global Brain-computer Interface System Price (K US$/Unit) by Type (2021–2026)
Table 61. Global Brain-computer Interface System Price (K US$/Unit) by Type (2027–2032)
Table 62. Global Brain-computer Interface System Sales (K Units) by Application (2021–2026)
Table 63. Global Brain-computer Interface System Sales (K Units) by Application (2027–2032)
Table 64. Global Brain-computer Interface System Sales Market Share by Application (2021–2026)
Table 65. Global Brain-computer Interface System Sales Market Share by Application (2027–2032)
Table 66. Global Brain-computer Interface System Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Brain-computer Interface System Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Brain-computer Interface System Revenue Market Share by Application (2021–2026)
Table 69. Global Brain-computer Interface System Revenue Market Share by Application (2027–2032)
Table 70. Global Brain-computer Interface System Price (K US$/Unit) by Application (2021–2026)
Table 71. Global Brain-computer Interface System Price (K US$/Unit) by Application (2027–2032)
Table 72. Neuralink Company Information
Table 73. Neuralink Description and Business Overview
Table 74. Neuralink Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 75. Neuralink Brain-computer Interface System Product
Table 76. Neuralink Recent Developments/Updates
Table 77. OpenBCI Company Information
Table 78. OpenBCI Description and Business Overview
Table 79. OpenBCI Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 80. OpenBCI Brain-computer Interface System Product
Table 81. OpenBCI Recent Developments/Updates
Table 82. NeuroPace Company Information
Table 83. NeuroPace Description and Business Overview
Table 84. NeuroPace Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 85. NeuroPace Brain-computer Interface System Product
Table 86. NeuroPace Recent Developments/Updates
Table 87. Emotiv Company Information
Table 88. Emotiv Description and Business Overview
Table 89. Emotiv Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 90. Emotiv Brain-computer Interface System Product
Table 91. Emotiv Recent Developments/Updates
Table 92. NeuroSky Company Information
Table 93. NeuroSky Description and Business Overview
Table 94. NeuroSky Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 95. NeuroSky Brain-computer Interface System Product
Table 96. NeuroSky Recent Developments/Updates
Table 97. ANT Neuro Company Information
Table 98. ANT Neuro Description and Business Overview
Table 99. ANT Neuro Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 100. ANT Neuro Brain-computer Interface System Product
Table 101. ANT Neuro Recent Developments/Updates
Table 102. Blackrock Neurotech Company Information
Table 103. Blackrock Neurotech Description and Business Overview
Table 104. Blackrock Neurotech Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 105. Blackrock Neurotech Brain-computer Interface System Product
Table 106. Blackrock Neurotech Recent Developments/Updates
Table 107. Synchron Company Information
Table 108. Synchron Description and Business Overview
Table 109. Synchron Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 110. Synchron Brain-computer Interface System Product
Table 111. Synchron Recent Developments/Updates
Table 112. g.tec medical engineering GmbH Company Information
Table 113. g.tec medical engineering GmbH Description and Business Overview
Table 114. g.tec medical engineering GmbH Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 115. g.tec medical engineering GmbH Brain-computer Interface System Product
Table 116. g.tec medical engineering GmbH Recent Developments/Updates
Table 117. Brain Products Company Information
Table 118. Brain Products Description and Business Overview
Table 119. Brain Products Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 120. Brain Products Brain-computer Interface System Product
Table 121. Brain Products Recent Developments/Updates
Table 122. Bitbrain Company Information
Table 123. Bitbrain Description and Business Overview
Table 124. Bitbrain Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 125. Bitbrain Brain-computer Interface System Product
Table 126. Bitbrain Recent Developments/Updates
Table 127. Precision Neuroscience Company Information
Table 128. Precision Neuroscience Description and Business Overview
Table 129. Precision Neuroscience Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 130. Precision Neuroscience Brain-computer Interface System Product
Table 131. Precision Neuroscience Recent Developments/Updates
Table 132. Paradromics Company Information
Table 133. Paradromics Description and Business Overview
Table 134. Paradromics Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 135. Paradromics Brain-computer Interface System Product
Table 136. Paradromics Recent Developments/Updates
Table 137. InteraXon Company Information
Table 138. InteraXon Description and Business Overview
Table 139. InteraXon Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 140. InteraXon Brain-computer Interface System Product
Table 141. InteraXon Recent Developments/Updates
Table 142. Neurable Company Information
Table 143. Neurable Description and Business Overview
Table 144. Neurable Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 145. Neurable Brain-computer Interface System Product
Table 146. Neurable Recent Developments/Updates
Table 147. Mentalab Company Information
Table 148. Mentalab Description and Business Overview
Table 149. Mentalab Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 150. Mentalab Brain-computer Interface System Product
Table 151. Mentalab Recent Developments/Updates
Table 152. mBrainTrain Company Information
Table 153. mBrainTrain Description and Business Overview
Table 154. mBrainTrain Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 155. mBrainTrain Brain-computer Interface System Product
Table 156. mBrainTrain Recent Developments/Updates
Table 157. Neuroelectrics Company Information
Table 158. Neuroelectrics Description and Business Overview
Table 159. Neuroelectrics Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 160. Neuroelectrics Brain-computer Interface System Product
Table 161. Neuroelectrics Recent Developments/Updates
Table 162. CGX Systems (formerly Cognionics) Company Information
Table 163. CGX Systems (formerly Cognionics) Description and Business Overview
Table 164. CGX Systems (formerly Cognionics) Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 165. CGX Systems (formerly Cognionics) Brain-computer Interface System Product
Table 166. CGX Systems (formerly Cognionics) Recent Developments/Updates
Table 167. Neurosity Company Information
Table 168. Neurosity Description and Business Overview
Table 169. Neurosity Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 170. Neurosity Brain-computer Interface System Product
Table 171. Neurosity Recent Developments/Updates
Table 172. Wearable Sensing Company Information
Table 173. Wearable Sensing Description and Business Overview
Table 174. Wearable Sensing Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 175. Wearable Sensing Brain-computer Interface System Product
Table 176. Wearable Sensing Recent Developments/Updates
Table 177. Compumedics Neuroscan Company Information
Table 178. Compumedics Neuroscan Description and Business Overview
Table 179. Compumedics Neuroscan Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 180. Compumedics Neuroscan Brain-computer Interface System Product
Table 181. Compumedics Neuroscan Recent Developments/Updates
Table 182. SmartCap(Wenco) Company Information
Table 183. SmartCap(Wenco) Description and Business Overview
Table 184. SmartCap(Wenco) Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 185. SmartCap(Wenco) Brain-computer Interface System Product
Table 186. SmartCap(Wenco) Recent Developments/Updates
Table 187. Shimadzu Company Information
Table 188. Shimadzu Description and Business Overview
Table 189. Shimadzu Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 190. Shimadzu Brain-computer Interface System Product
Table 191. Shimadzu Recent Developments/Updates
Table 192. BrainCo Company Information
Table 193. BrainCo Description and Business Overview
Table 194. BrainCo Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 195. BrainCo Brain-computer Interface System Product
Table 196. BrainCo Recent Developments/Updates
Table 197. Neuracle Technology Company Information
Table 198. Neuracle Technology Description and Business Overview
Table 199. Neuracle Technology Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 200. Neuracle Technology Brain-computer Interface System Product
Table 201. Neuracle Technology Recent Developments/Updates
Table 202. CUSOFT Company Information
Table 203. CUSOFT Description and Business Overview
Table 204. CUSOFT Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 205. CUSOFT Brain-computer Interface System Product
Table 206. CUSOFT Recent Developments/Updates
Table 207. Deayea Company Information
Table 208. Deayea Description and Business Overview
Table 209. Deayea Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 210. Deayea Brain-computer Interface System Product
Table 211. Deayea Recent Developments/Updates
Table 212. Entertech Company Information
Table 213. Entertech Description and Business Overview
Table 214. Entertech Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 215. Entertech Brain-computer Interface System Product
Table 216. Entertech Recent Developments/Updates
Table 217. HNNK Company Information
Table 218. HNNK Description and Business Overview
Table 219. HNNK Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 220. HNNK Brain-computer Interface System Product
Table 221. HNNK Recent Developments/Updates
Table 222. StairMed Company Information
Table 223. StairMed Description and Business Overview
Table 224. StairMed Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 225. StairMed Brain-computer Interface System Product
Table 226. StairMed Recent Developments/Updates
Table 227. NeuroXess Company Information
Table 228. NeuroXess Description and Business Overview
Table 229. NeuroXess Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 230. NeuroXess Brain-computer Interface System Product
Table 231. NeuroXess Recent Developments/Updates
Table 232. Enlight Medical Company Information
Table 233. Enlight Medical Description and Business Overview
Table 234. Enlight Medical Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 235. Enlight Medical Brain-computer Interface System Product
Table 236. Enlight Medical Recent Developments/Updates
Table 237. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Company Information
Table 238. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Description and Business Overview
Table 239. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 240. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Product
Table 241. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Recent Developments/Updates
Table 242. Hanix Company Information
Table 243. Hanix Description and Business Overview
Table 244. Hanix Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 245. Hanix Brain-computer Interface System Product
Table 246. Hanix Recent Developments/Updates
Table 247. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Company Information
Table 248. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Description and Business Overview
Table 249. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 250. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Product
Table 251. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Recent Developments/Updates
Table 252. Beijing Xinzhida Neural Technology Co., Ltd Company Information
Table 253. Beijing Xinzhida Neural Technology Co., Ltd Description and Business Overview
Table 254. Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 255. Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Product
Table 256. Beijing Xinzhida Neural Technology Co., Ltd Recent Developments/Updates
Table 257. Nanjing Vishee Medical Technology Co., Ltd. Company Information
Table 258. Nanjing Vishee Medical Technology Co., Ltd. Description and Business Overview
Table 259. Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 260. Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Product
Table 261. Nanjing Vishee Medical Technology Co., Ltd. Recent Developments/Updates
Table 262. Xiangyu Medical Co.,Ltd. Company Information
Table 263. Xiangyu Medical Co.,Ltd. Description and Business Overview
Table 264. Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 265. Xiangyu Medical Co.,Ltd. Brain-computer Interface System Product
Table 266. Xiangyu Medical Co.,Ltd. Recent Developments/Updates
Table 267. Jiangsu Apon Medical Technology Co.,Ltd. Company Information
Table 268. Jiangsu Apon Medical Technology Co.,Ltd. Description and Business Overview
Table 269. Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 270. Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Product
Table 271. Jiangsu Apon Medical Technology Co.,Ltd. Recent Developments/Updates
Table 272. Key Raw Materials Lists
Table 273. Raw Materials Key Suppliers Lists
Table 274. Brain-computer Interface System Distributors List
Table 275. Brain-computer Interface System Customers List
Table 276. Brain-computer Interface System Market Trends
Table 277. Brain-computer Interface System Market Drivers
Table 278. Brain-computer Interface System Market Challenges
Table 279. Brain-computer Interface System Market Restraints
Table 280. Research Programs/Design for This Report
Table 281. Key Data Information from Secondary Sources
Table 282. Key Data Information from Primary Sources
Table 283. Authors List of This Report
List of Figures
Figure 1. Product Picture of Brain-computer Interface System
Figure 2. Global Brain-computer Interface System Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Brain-computer Interface System Market Share by Type: 2025 & 2032
Figure 4. Non-Invasive Product Picture
Figure 5. Partially Invasive Product Picture
Figure 6. Invasive Product Picture
Figure 7. Global Brain-computer Interface System Market Value by Signal Acquisition Channel Count (US$ Million), 2021–2032
Figure 8. Global Brain-computer Interface System Market Share by Signal Acquisition Channel Count: 2025 vs 2032
Figure 9. 1 To 8 Channels Product Picture
Figure 10. 9 To 32 Channels Product Picture
Figure 11. 33 To 128 Channels Product Picture
Figure 12. 128 To 256 Channels Product Picture
Figure 13. Global Brain-computer Interface System Market Value by Primary Signal Modality (US$ Million), 2021–2032
Figure 14. Global Brain-computer Interface System Market Share by Primary Signal Modality: 2025 vs 2032
Figure 15. EEG Product Picture
Figure 16. ECoG Product Picture
Figure 17. Spikes & LFPs Product Picture
Figure 18. fNIRS, MEG and Others Product Picture
Figure 19. Global Brain-computer Interface System Market Value by Application (US$ Million), 2021–2032
Figure 20. Global Brain-computer Interface System Market Share by Application: 2025 & 2032
Figure 21. Medical Rehabilitation
Figure 22. Daily Life and Entertainment Consumption
Figure 23. Industrial Control
Figure 24. Traffic Driving
Figure 25. Research & Education
Figure 26. Military and Others
Figure 27. Global Brain-computer Interface System Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 28. Global Brain-computer Interface System Market Size (US$ Million), 2021–2032
Figure 29. Global Brain-computer Interface System Sales (K Units), 2021–2032
Figure 30. Global Brain-computer Interface System Average Price (K US$/Unit), 2021–2032
Figure 31. Brain-computer Interface System Report Years Considered
Figure 32. Brain-computer Interface System Sales Share by Manufacturers in 2025
Figure 33. Global Brain-computer Interface System Revenue Share by Manufacturers in 2025
Figure 34. Top 5 and Top 10 Global Brain-computer Interface System Players: Market Share by Revenue in Brain-computer Interface System in 2025
Figure 35. Brain-computer Interface System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 36. Global Brain-computer Interface System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 37. North America Brain-computer Interface System Sales Market Share by Country (2021–2032)
Figure 38. North America Brain-computer Interface System Revenue Market Share by Country (2021–2032)
Figure 39. United States Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Canada Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Europe Brain-computer Interface System Sales Market Share by Country (2021–2032)
Figure 42. Europe Brain-computer Interface System Revenue Market Share by Country (2021–2032)
Figure 43. Germany Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. France Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. U.K. Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Italy Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Russia Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Asia Pacific Brain-computer Interface System Sales Market Share by Region (2021–2032)
Figure 49. Asia Pacific Brain-computer Interface System Revenue Market Share by Region (2021–2032)
Figure 50. China Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Japan Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. South Korea Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. India Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Australia Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. China Taiwan Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Indonesia Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Thailand Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Malaysia Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Latin America Brain-computer Interface System Sales Market Share by Country (2021–2032)
Figure 60. Latin America Brain-computer Interface System Revenue Market Share by Country (2021–2032)
Figure 61. Mexico Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Brazil Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Argentina Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Middle East and Africa Brain-computer Interface System Sales Market Share by Country (2021–2032)
Figure 65. Middle East and Africa Brain-computer Interface System Revenue Market Share by Country (2021–2032)
Figure 66. Turkey Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 67. Saudi Arabia Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 68. UAE Brain-computer Interface System Revenue Growth Rate (US$ Million), 2021–2032
Figure 69. Global Sales Market Share of Brain-computer Interface System by Type (2021–2032)
Figure 70. Global Revenue Market Share of Brain-computer Interface System by Type (2021–2032)
Figure 71. Global Brain-computer Interface System Price (K US$/Unit) by Type (2021–2032)
Figure 72. Global Sales Market Share of Brain-computer Interface System by Application (2021–2032)
Figure 73. Global Revenue Market Share of Brain-computer Interface System by Application (2021–2032)
Figure 74. Global Brain-computer Interface System Price (K US$/Unit) by Application (2021–2032)
Figure 75. Brain-computer Interface System Value Chain
Figure 76. Channels of Distribution (Direct Vs Distribution)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Brain-computer Interface System market?
The top companies in the global Brain-computer Interface System market are Neuralink、OpenBCI、NeuroPace.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Brain-computer Interface System market size from 2026 to 2032?
What was the global market size of Brain-computer Interface System in 2026?
What was the global market size of Brain-computer Interface System in 2032?
Related Reports
Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Brain-computer Interface System was estimated to be worth US$ 836 million in 2025 and is projected to reach US$ 2962 million, growing at a CAGR of 20.4% from 2026 to 2032.
Published Date: 2026-07-26
Pages: 195
USD 3950.00
(Single User License)
Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Brain-computer Interface System market is projected to grow from US$ 836 million in 2025 to US$ 2962 million by 2032, at a CAGR of 20.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-26
Pages: 228
USD 4900.00
(Single User License)
Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Brain-computer Interface System market size was US$ 836 million in 2025 and is forecast to reach a readjusted size of US$ 2962 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Published Date: 2026-07-26
Pages: 195
USD 4250.00
(Single User License)
Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Brain-computer Interface System market is projected to grow from US$ 186 million in 2024 to US$ 223 million by 2031, at a CAGR of 2.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 134
USD 4900.00
(Single User License)
Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Brain-computer Interface System market size was US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 96
USD 4250.00
(Single User License)
Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Brain-computer Interface System was estimated to be worth US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 113
USD 3950.00
(Single User License)
Global Brain-computer Interface System Market Research Report 2025
The global market for Brain-computer Interface System was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 223 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Published Date: 2025-02-20
Pages: 88
USD 2900.00
(Single User License)
Global Brain-computer Interface System Market Insights, Forecast to 2030
Market Analysis and Insights: Global Brain-computer Interface System Market
Published Date: 2024-04-08
Pages: 114
USD 4900.00
(Single User License)
Brain-computer Interface System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Brain-computer Interface System was estimated to be worth US$ 177 million in 2023 and is forecast to a readjusted size of US$ 212.7 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030
Published Date: 2024-02-22
Pages: 106
USD 3950.00
(Single User License)
Global Brain-computer Interface System Market Research Report 2024
The global Brain-computer Interface System market was valued at US$ 177 million in 2023 and is anticipated to reach US$ 212.7 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 83
USD 2900.00
(Single User License)
Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Brain-computer Interface System was estimated to be worth US$ 836 million in 2025 and is projected to reach US$ 2962 million, growing at a CAGR of 20.4% from 2026 to 2032.
Published: 2026-07-26
Pages: 195
USD 3950.00 (Single User License)Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Brain-computer Interface System market is projected to grow from US$ 836 million in 2025 to US$ 2962 million by 2032, at a CAGR of 20.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-26
Pages: 228
USD 4900.00 (Single User License)Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Brain-computer Interface System market size was US$ 836 million in 2025 and is forecast to reach a readjusted size of US$ 2962 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Published: 2026-07-26
Pages: 195
USD 4250.00 (Single User License)Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Brain-computer Interface System market is projected to grow from US$ 186 million in 2024 to US$ 223 million by 2031, at a CAGR of 2.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 134
USD 4900.00 (Single User License)Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Brain-computer Interface System market size was US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 96
USD 4250.00 (Single User License)Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Brain-computer Interface System was estimated to be worth US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 113
USD 3950.00 (Single User License)Global Brain-computer Interface System Market Research Report 2025
The global market for Brain-computer Interface System was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 223 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Published: 2025-02-20
Pages: 88
USD 2900.00 (Single User License)Global Brain-computer Interface System Market Insights, Forecast to 2030
Market Analysis and Insights: Global Brain-computer Interface System Market
Published: 2024-04-08
Pages: 114
USD 4900.00 (Single User License)Brain-computer Interface System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Brain-computer Interface System was estimated to be worth US$ 177 million in 2023 and is forecast to a readjusted size of US$ 212.7 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030
Published: 2024-02-22
Pages: 106
USD 3950.00 (Single User License)Global Brain-computer Interface System Market Research Report 2024
The global Brain-computer Interface System market was valued at US$ 177 million in 2023 and is anticipated to reach US$ 212.7 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
COMPETITIVE LANDSCAPE ANALYSIS
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now